On-Demand Webinar
Life sciences companies are leveraging digitalization, new and evolving technologies, and third-party providers to boost innovation, quality, and speed.
These compelling advances also introduce cybersecurity vulnerabilities. Recent failures within companies and their third-party providers have led to significant and mounting harms. As an essential constituent of technology and business strategy, threats and risks must be evaluated and managed.
Understanding current and emerging cybersecurity threats and risks and how to deal with them is critical to the protection of intellectual properties, data, and patient privacy, and to continuous regulatory compliance.
What You'll Learn
- How digitalization, new technologies, and third-party providers expand the cybersecurity attack surface for life sciences organizations.
- Why recent failures within companies and their third-party providers have led to significant and mounting harms.
- How to evaluate and manage cybersecurity threats and risks as an essential part of technology and business strategy.
- What it takes to protect intellectual property, data, and patient privacy from current and emerging threats.
- How a managed approach to cybersecurity risk supports continuous regulatory compliance.
Fill out the form to access the full-length webinar.
Watch the On-Demand Webinar
Here is a sampling of what Roger and Dom shared in this webinar.
At USDM, we view cybersecurity not as a one-time project but as an ongoing discipline that has to be embedded in technology and business strategy. In a regulated life sciences environment, protecting data and patient privacy and maintaining continuous regulatory compliance go hand in hand — which is why strong life sciences cybersecurity and disciplined third-party risk management are essential as companies adopt new technologies and providers.
Have questions? Peruse the Q&A from the webinar, or contact us with your inquiry.
Frequently Asked Questions
Why are life sciences companies increasingly exposed to cybersecurity threats?
Life sciences companies are leveraging digitalization, new and evolving technologies, and third-party providers to boost innovation, quality, and speed. These advances deliver real benefits, but they also introduce cybersecurity vulnerabilities that must be evaluated and managed as part of technology and business strategy.
What is at stake if these threats are not addressed?
Recent failures within companies and their third-party providers have led to significant and mounting harms. Understanding and managing these threats is critical to protecting intellectual property, data, and patient privacy, and to maintaining continuous regulatory compliance.
How do third-party providers factor into cybersecurity risk?
Third-party providers are part of how life sciences companies innovate and move faster, but failures within those providers can create the same harms as internal failures. That makes disciplined third-party risk management an essential part of an overall cybersecurity strategy.
How does cybersecurity relate to regulatory compliance?
Protecting data and patient privacy from current and emerging threats is directly tied to continuous regulatory compliance. Managing cybersecurity threats and risks helps life sciences companies safeguard regulated data while keeping pace with the technologies and providers they depend on.
How can I see the full discussion?
Fill out the form to access the full-length on-demand webinar, where Roger Davy and Dom Glavach discuss current and emerging cybersecurity threats and how life sciences companies can deal with them.
Strengthen Your Cybersecurity Posture
Ready to evaluate and manage the cybersecurity threats and risks facing your organization? Contact us to talk with USDM about protecting your intellectual property, data, and patient privacy while maintaining continuous regulatory compliance.
About the Presenters
Roger Davy, Director, Customer Engagement
Dom Glavach, Chief Security Officer and Chief Security Strategist, CyberSN